To access all features of this site, you must enable Javascript. Here are the instructions for enabling Javascript in your web browser.
To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
All the news of the Institute of life sciences Frédéric Joliot
The psychiatry team of the clinical research UNIACT Lab at NeuroSpin, have published a study comparing with multimodal MRI two very frequent psychiatric conditions: high-functioning autism (also known as Asperger's syndrom) and schizophrenia.
The group of Marc Dhenain (MIRCen) has developed an MRI microscopy technique that can track in vivo the fate of amyloid plaques. This technique was used to characterize an immunotherapy targeting specific forms of amyloid (called protofibrillar). The article, published in collaboration with Sanofi, demonstrates an effective partnership between the CEA and industrial partners.
Recent work from the IMIV research lab suggests that tumor heterogeneity measured in vivo using PET images actually reflects the biological heterogeneity as measured ex vivo using pathological slides.
Two researchers of Neurospin have just revealed that the brain possesses a network of cerebral areas involved in the high-level mathematical as in the simplest arithmetic operations.
For the first time in human, a study proves that microglial activation seems to play a protective role in the clinical progression of the disease at these early stages of Alzheimer's disease.
In the context of a collaboration with the I²BM institute, researchers from SCBM have designed micellar vectors for targeting and visual delineation of tumors.
On September 17, the jury for Societal Resilience Trophies of the French High Committee for Civil Defence (HCFDC) awarded to the team of Laurent Bellanger (CEA-IBITECS) the price of technological innovation for the development of the diagnostic test for Ebola virus disease, named Ebola eZYSCREEN®.
Two French research teams have recently shown in a rodent model that overexpression of an enzyme capable of eliminating excess cholesterol in the brain can act in a beneficial way on the tau component of the disease to completely correct it.
Top page
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.